The nationwide experiment will initially include around 100,000 volunteers.
The drugs’ disruption of the microbiome makes a subsequent flavivirus infection more severe.
The Scientist
Most Recent
A study finds that the vaccine’s effects wear off as a person ages, suggesting a need for booster shots.
Volvox barberi actively organize themselves into large colonies that optimize space.
A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.
A device dubbed the “mother machine” enables real-time observation of mutagenesis in single bacterial cells.
Biodegradable pigments could be custom-grown by bacteria in the future, say researchers.
At Hampshire College, students and faculty use the amoeba Physarum polycephalum—both a “visiting scholar” and a model organism—to examine human societal and political quandaries.
A molecule produced by a strain of Staphylococcus epidermis interferes with DNA synthesis.
In response to short DNA fragments, lymphocytes release mitochondrial DNA that helps trigger an immune response.
After discovering a novel organelle found in protozoan parasites, the University of Pennsylvania’s Roos created a widely used eukaryotic pathogen database.
Popular Now
-
The Nutshell Estonia Offers Free Genetic Testing to Residents -
Daily News Human Brain Organoids Thrive in Mouse Brains After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
-
The Nutshell New Ovarian Cancer Vaccine Shows Promise A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
-
Daily News The Second March for Science a Smaller Affair Many cities around the globe, including Washington, DC, saw shrunken crowd sizes, and numerous events turned into rallies rather than processions.
Current Issue
© 1986-2018 The Scientist
